Your session is about to expire
← Back to Search
Safe and Sound Protocol for Post-Traumatic Stress Disorder
Study Summary
This trial aims to study the effects of the SSP on individuals with PTSD.
- Post Traumatic Stress Disorder
- Anxiety
Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I'm sorry, but this is not a screening criterion. It appears to be a statement about a specific client at a psychology clinic.You have already agreed with your therapist to use SSP (Safe and Sound Protocol) as part of your therapy.You have been diagnosed with post-traumatic stress disorder (PTSD) or other unspecified trauma.
- Group 1: Psychotherapy (treatment as usual)
- Group 2: Psychotherapy + SSP
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Are there vacant positions available in this experiment for potential participants?
"According to clinicaltrials.gov, this particular medical study is not currently seeking any new participants. This trial was opened on July 12th 2021 and updated lastly on September 15th 2022; however there are almost 1,000 other studies that are actively recruiting patients at the present time."
What are the major goals that this clinical experiment is aiming to achieve?
"Over a period of 2-4 months, this research is aiming to evaluate the impact of reducing Anxiety. To support these objectives, secondary metrics such as Mean heart period during posture shifts using Photoplethysmography, Self-reported disruption of autonomic reactivity with Body Perception Questionnaire and Respiratory sinus arrhythmia (RSA) measured through earlobe pulse sensor will be assessed. High values in each metric may lead to greater therapeutic efficacy."
Who else is applying?
What state do they live in?
What site did they apply to?
What portion of applicants met pre-screening criteria?
How many prior treatments have patients received?
Why did patients apply to this trial?
What questions have other patients asked about this trial?
Share this study with friends
Copy Link
Messenger